Abbott Healthcare (ABT) under regulatory scrutiny in India amid an investigation into cough syrup abuse
Newsquawk Staff ·
Abbott Healthcare (ABT) under regulatory scrutiny in India amid an investigation into cough syrup abuse.
What it means
Abbott Healthcare is facing regulatory scrutiny in India due to an investigation into the abuse of its cough syrup. This could impact the company’s reputation and potentially lead to financial ramifications, especially if it results in significant fines or operational restrictions. Keeping an eye on how this situation develops will be crucial, as it may affect investor sentiment toward the stock and the broader health care sector.
- The Mosaic Company (MOS) Q3 2026 (USD): Adj. EPS -0.19 (exp. -0.01), Revenue 3.1bln (exp. 3.05bln)
- [ANALYSIS] US Midterms: Senate, Governor and PUC indicative timings
- Arista Networks Inc. (ANET) Q3 2026 (USD): Adj. EPS 1.20 (exp. 1.08), Revenue 3.66bln (exp. 3.33bln)
- Newsquawk Daily US Earnings Estimates - 4th November 2026: CVS, UBER, MCD, QCOM, MCK, ARM
- [ANALYSIS] US Midterms: Senate, Governor and PUC indicative timings
Related headlines
- Booking Holdings Inc. (BKNG) Q3 2026 (USD): Adj. EPS 4.66 (exp. 4.49), Revenue 8.9bln (exp. 9.55bln)5 days ago
- Oracle (ORCL) executive VP told Nikkei the Co. has no plans to slow down its investment in Japan, emphasising that the country remains a key market5 days ago
- Ambani’s Jio Platforms held talks to license technology to Comcast (CMCSA) and Charter (CHTR) in exchange for shares, according to sources5 days ago
- Uber’s (UBER) Jill Hazelbaker to join OpenAI as Chief Corporate Affairs Officer, reports The Information5 days ago
- Apple (AAPL) opens Siri AI preview to all developers5 days ago
- Nvidia’s (NVDA) market dominance helps it influence policy and customers, reports The Information5 days ago
- Sysco (SYY) executives expect basket inflation below 1% in Q2 and between 1% and 1.5% for the full year, down from its budgeted 1.5-2% assumption, creating near term P&L pressure5 days ago
- US EQUITY OPEN: Tech pares back some recent losses as US/Iran negotiations and US midterms are in focus5 days ago
- Spanish competition authority (CNMC) launches disciplinary proceedings against Apple (AAPL) and Amazon (AMZN)5 days ago
- Amazon's (AMZN) AWS and GOSH are to deploy emerging technologies in healthcare5 days ago
- Williams (WMB) says elections are not expected to delay data center projects5 days ago
- Pershing Square's Bill Ackman says Netflix (NFLX) stock is 'incredibly cheap'5 days ago
- US BROKER MOVES: BE upgraded at Barclays; MRVL downgraded at TD Cowen5 days ago
- US PRE-MARKET MOVERS: AAPL, PLTR, ON, FN, LSCC, SHOP, KDP, FISV, DD5 days ago
- Keurig Dr Pepper Inc. (KDP) Q3 2026 (USD): Adj. EPS 0.66 (exp. 0.62), Revenue 7.3bln (exp. 7.33bln), Adj. operating income 1.7bln (exp. 1.6bln); reaffirms guidance5 days ago